SFX by Ex Libris Inc.

Title:	A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation
Source:	Science [0036-8075] McQuade, T J yr:1990

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Lu, Yipin P. "Binding free energy contributions of interfacial waters in HIV-1 protease/inhibitor complexes." Journal of the American Chemical Society 128.36 (2006): 11830-11839.
description	2.	Lam, P. "Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors." Science 263.5145 (1994): 380-384.
description	3.	Miller, M. "Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution." Science 246.4934 (1990): 1149-52.
description	4.	Kesson, A M M. "Human immunodeficiency virus type 1 infection of human placental macrophages in vitro." The journal of infectious diseases 168.3 (1993): 571-9.
description	5.	Hill, M. "The packaging and maturation of the HIV-1 Pol proteins." Current HIV research 3.1 (2004): 73-85.
description	6.	Pierce, Michael E. "Stereoselective Synthesis of HIV-1 Protease Inhibitor DMP 323." Journal of organic chemistry 61.2 (1996): 444-450.
description	7.	Houck, Wendy J. J. "Temperature effects on the catalytic activity of the D38E mutant of 3-Oxo-delta(super 5)-steroid isomerase: Favorable enthalpies and entropies of activation relative to the noenzymatic reaction catalyzed by acetate ion." Journal of the American Chemical Society 126.50 (2004): 16416-16425.
description	8.	Lu, Y. "Analysis of ligand-bound water molecules in high-resolution crystal structures of protein-ligand complexes." Journal of chemical information and modeling 47.2 (2007): 668-675.
description	9.	Wlodawer, A. "Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease." Science 245.4918 (1989): 616-21.
description	10.	ROBERTS, N A A. "RATIONAL DESIGN OF PEPTIDE-BASED HIV PROTEINASE-INHIBITORS." Science 248.4953 (1990): 358-361.
description	11.	Skalova, T. "HIV-1 protease mutations and inhibitor modifications monitored on a series of complexes. Structural basis for the effect of the A71V mutation on the active site." Journal of medicinal chemistry 49.19 (2006): 5777-5784.
description	12.	Barillari, C. "Classification of water molecules in protein binding sites." Journal of the American Chemical Society 129.9 (2007): 2577-2587.
description	13.	Hout, D. "Vpu: A multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1." Current HIV research 2.3 (2004): 255-270.
description	14.	Co, E. "Proteolytic processing mechanisms of a miniprecursor of the aspartic protease of human immunodeficiency virus type 1." Biochemistry (1994): 1248-54.
description	15.	Jacks, T. "Characterization of ribosomal frameshifting in HIV-1 gag-pol expression." Nature 331.6153 (1988): 280-3.
description	16.	Buxton, P. "Analysis of the contribution of reverse transcriptase and integrase proteins to retroviral RNA dimer conformation." Journal of virology 79.10 (2005): 6338-6348.
description	17.	Chellappan, S. "Design of mutation-resistant HIV protease inhibitors with the substrate envelope hypothesis." Chemical biology & drug design 69.5 (2007): 298-313.
description	18.	Brewster, M. "Cyclodextrins as pharmaccutical solubilizers." Advanced Drug Delivery Reviews 59.7 (2007): 645-666.
description	19.	SWAIN, A. "X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A COMPLEX BETWEEN A SYNTHETIC PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS-1 AND A SUBSTRATE-BASED HYDROXYETHYLAMINE INHIBITOR." Proceedings of the National Academy of Sciences of the United States of America 87.22 (1990): 8805-8809.
description	20.	Varghese, Joseph N. "Development of neuraminidase inhibitors as anti-influenza virus drugs." Drug development research 46.3-4 (1999): 176-196.